Severe Metabolic Acidosis in Adult Patients with Duchenne Muscular Dystrophy

被引:14
作者
Lo Cascio, Christian M. [1 ]
Latshang, Tsogyal D. [1 ]
Kohler, Malcolm [1 ]
Fehr, Thomas [2 ]
Bloch, Konrad E. [1 ]
机构
[1] Univ Zurich Hosp, Div Pulm, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland
关键词
Duchenne muscular dystrophy; Metabolic acidosis; Positive pressure ventilation; Constipation; DISABILITY;
D O I
10.1159/000358439
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Duchenne muscular dystrophy (DMD) leads to progressive paresis, respiratory failure and premature death. Long-term positive pressure ventilation can improve quality of life and survival, but previously unrecognized complications may arise. We analyzed the characteristics of severe metabolic acidosis occurring in 8 of 55 DMD patients, of 20-36 years of age, observed over a 5-year period. All patients were on positive pressure ventilation and were being treated for chronic constipation. Before admission, they had had a reduced intake of fluids and food. Upon examination, they were severely ill, dyspneic and suffering from abdominal discomfort. Metabolic acidosis with a high anion gap was noted in 5 of the 8 patients and with a normal anion gap in the other 3. They all recovered after the administration of fluids and nutrition, the regulation of bowel movements and treatment with antibiotics, as appropriate. Metabolic acidosis is a life-threatening, potentially preventable complication in older DMD patients. Early recognition, subsequent administration of fluids, nutrition and antibiotics and regulation of bowel movements seem to be essential. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:499 / 503
页数:5
相关论文
共 12 条
[1]   Nitric oxide regenerates the normal colonic peristaltic activity in mdx dystrophic mouse [J].
Azzena, GB ;
Mancinelli, R .
NEUROSCIENCE LETTERS, 1999, 261 (1-2) :9-12
[2]   GASTRIC HYPOMOTILITY IN DUCHENNES MUSCULAR-DYSTROPHY [J].
BAROHN, RJ ;
LEVINE, EJ ;
OLSON, JO ;
MENDELL, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (01) :15-18
[3]   DUCHENNE MUSCULAR-DYSTROPHY - PATTERNS OF CLINICAL PROGRESSION AND EFFECTS OF SUPPORTIVE THERAPY [J].
BROOKE, MH ;
FENICHEL, GM ;
GRIGGS, RC ;
MENDELL, JR ;
MOXLEY, R ;
FLORENCE, J ;
KING, WM ;
PANDYA, S ;
ROBISON, J ;
SCHIERBECKER, J ;
SIGNORE, L ;
MILLER, JP ;
GILDER, BF ;
KAISER, KK ;
MANDEL, S ;
ARFKEN, C .
NEUROLOGY, 1989, 39 (04) :475-481
[4]   GENETIC AND CLINICAL CORRELATIONS OF XP21 MUSCULAR-DYSTROPHY [J].
BUSHBY, KMD .
JOURNAL OF INHERITED METABOLIC DISEASE, 1992, 15 (04) :551-564
[5]   DYSTROPHIN - THE PROTEIN PRODUCT OF THE DUCHENNE MUSCULAR-DYSTROPHY LOCUS [J].
HOFFMAN, EP ;
BROWN, RH ;
KUNKEL, LM .
CELL, 1987, 51 (06) :919-928
[6]   Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy [J].
Kohler, M ;
Clarenbach, CF ;
Boeni, L ;
Brack, T ;
Russi, EW ;
Bloch, KE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (08) :1032-1036
[7]   Disability and survival in Duchenne muscular dystrophy [J].
Kohler, M. ;
Clarenbach, C. F. ;
Bahler, C. ;
Brack, T. ;
Russi, E. W. ;
Bloch, K. E. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (03) :320-325
[8]  
LEON SH, 1986, GASTROENTEROLOGY, V90, P455, DOI 10.1016/0016-5085(86)90948-0
[9]  
Lo Cascio CM, 2012, EUR RESP J S56, V40, p296s
[10]  
Matsumura T, 2000, Rinsho Shinkeigaku, V40, P439